Biogen Idec (BIIB) - Cash Funds per Share

Corporate emblem and logo of Biogen Inc. (BIIB)

Biogen Inc. (BIIB) is shifting its focus from sclerosis therapy toward high-risk Alzheimer's research, although the success of Leqembi and Skyclarys is already generating tangible profits. The historical level of cash per share confirms this transition, with 8.76 serving as the final level marker. Capital stability is further bolstered by streamlined cold chain logistics, which minimize the spoilage of high-cost drugs and support overall profitability.

Biogen Corp (BIIB) Cash per Share: for the period 07/04/2022 - 11/20/2026

Analytical breakdowns for Biogen Inc.

- market value and analyst target forecast:
- market capitalization indicators:
- cash position and cash flow details:
Summary company analysis:BIIB (Biogen Inc.)
Brand item of Biogen Inc

Biogen Inc. maintains its leadership status in developing therapies for the most complex neurological pathologies, which requires colossal R&D capital expenditures. Analyzing the cash per share allows for an assessment of business liquidity by dividing the total cash volume by the number of shares, demonstrating management's ability to accumulate resources to hedge against market volatility and ensure the company's fundamental stability.

Competing companies

NBIX: Amount of Cash per Share|Cash Funds per Share Regencell Bioscience Ltd (RGC)|Cash per Share axsome.com (AXSM)|Cash per Share ACAD (acadia-pharm.com)|XENE - Cash per Single Share|vikingtherapeutics.com - Cash per Share|Supernus Pharma (SUPN) - Cash per Single Share|CPRX: Cash per Share|Denali Therapeutics Inc. (DNLI) - Cash per Share|Cash Funds per Share Harmony Pharma|Cash Funds per Share BHVN|Cash per Single Share AMLX (Amylyx Pharmaceuticals, Inc.)|Cash per Single Share Trevi Corp TRVI|Cash Funds per Share praxismedicines.com PRAX|AVXL - Cash per Single Share|CeriBell EEG - Cash per Share|Cash on Hand per Share prothena.com|Alector Therapeutics (ALEC) - Cash Funds per Share|Annexon Biosciences Inc. - Amount of Cash per Share|OMER (Omeros Corp) - Cash per Share|Cash per Share neurogene.com|Cash per Share ACIU|VYGR - Cash on Hand per Share|Cash Funds per Share Neumora Therapeutics Inc NMRA|Cash Funds Calculated per Share Scilex Holding Co. (SCLX)|TVGN - Cash Funds per Share|Cash on Hand per Share alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Cash per Single Share|IKT: Cash Calculated per Single Share|Cash Funds per Share Cassava Sciences, Inc.|ASRT (assertiotx.com) - Cash Calculated per Single Share|Cash Funds per Share Coya (COYA)|VTGN - Cash on Hand per Share|Cash per Share OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Cash on Hand per Share|cervomed.com - Cash per Share|Amount of Cash per Share ATHE (Alterity Therapeutics Limited)|CLNN: Cash per Share|Cash per Single Share PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Cash per Share|Cash on Hand per Share Relmada Therapeutics Inc RLMD|Cash Funds per Share Annovis Bio Corporation (ANVS)|GRCE - Cash on Hand per Share|Cash Funds per Share Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Cash on Hand per Share|NeuroSense Therapeutics, Ltd. - Cash per Share|RVPH: Cash Funds per Share|MTVA: Cash per Share|NRXS - Cash Funds Calculated per Share|HSDT (Helius Medical Technologies Inc.) - Cash per Share|Cash on Hand per Share Passage Bio PASG|Cash Funds per Share Neuphoria (NEUP)|Cash per Share Minerva Neurosciences Corp (NERV)|Cash Funds per Share Athira ATHA|Cash per Share Addex ADXN|Alzamend - Cash per Share|Cash on Hand per Share Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Cash Funds per Share|KTTA: Cash Calculated per Single Share|Cash per Single Share CRGT|Avenue Therapeutics, Inc - Cash Money per Share|Cash Funds per Share Brainstorm Cell (BCLI)|CARA: Cash Money per Share|Chromocell Therapeutics Corp. - Cash per Single Share|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share